G. Lucas

发表

Longitudinal assessment of the effects of drug and alcohol abuse on HIV-1 treatment outcomes in an urban clinic

Richard D Moore, R. Chaisson, K. Gebo, 2002, AIDS.

Initial strategies for integrating buprenorphine into HIV care settings in the United States.

R. D. Bruce, L. Eldred, D. Fiellin, 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Vancomycin-resistant and vancomycin-susceptible enterococcal bacteremia: comparison of clinical features and outcomes.

C. Flexner, G. Lucas, R. Moore, 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

HIV Treatment Outcomes Among HIV-Infected, Opioid-Dependent Patients Receiving Buprenorphine/Naloxone Treatment within HIV Clinical Care Settings: Results From a Multisite Study

R. D. Bruce, F. Altice, P. Korthuis, 2011, Journal of acquired immune deficiency syndromes.

High HIV burden among people who inject drugs in 15 Indian cities

Elizabeth L. Ogburn, E. Ogburn, O. Laeyendecker, 2015, AIDS.

Beyond surveillance: a role for respondent-driven sampling in implementation science.

D. Celentano, S. Solomon, G. Lucas, 2013, American journal of epidemiology.

Renal Disease in Patients with HIV Infection

D. Fine, M. Perazella, G. Lucas, 2012, Drugs.

Injection Drug Network Characteristics Are Important Markers of HIV Risk Behavior and Lack of Viral Suppression

D. Celentano, S. Solomon, G. Lucas, 2017, Journal of acquired immune deficiency syndromes.

Effectiveness of highly active antiretroviral therapy among injection drug users with late-stage human immunodeficiency virus infection.

S. Galea, D. Vlahov, T. Sterling, 2005, American journal of epidemiology.

Integrating HCV testing with HIV programs improves hepatitis C outcomes in people who inject drugs: A cluster-randomized trial.

O. Laeyendecker, T. Quinn, D. Celentano, 2020, Journal of hepatology.

Clinical Pharmacology in HIV Therapy.

S. de Seigneux, G. Lucas, M. Atta, 2018, Clinical journal of the American Society of Nephrology : CJASN.

A systematic review of comprehensive interventions for substance abuse: Focus on victimization.

G. Lucas, Bushra Sabri, C. Greene, 2019, Aggression and violent behavior.

HIV and proteinuria in an injection drug user population.

D. Vlahov, G. Lucas, S. Mehta, 2010, Clinical journal of the American Society of Nephrology : CJASN.

The Impact of Hepatitis C Coinfection on Kidney Disease Related to Human Immunodeficiency Virus (HIV): A Biopsy Study

D. Fine, G. Nadkarni, G. Lucas, 2011, Medicine.

Decreased Kidney Function in a Community-based Cohort of HIV-Infected and HIV-Negative Individuals in Rakai, Uganda

O. Laeyendecker, D. Fine, R. Gray, 2010, Journal of acquired immune deficiency syndromes.

Kidney function and the risk of cardiovascular events in HIV-1-infected patients

Richard D Moore, D. Fine, G. Nadkarni, 2010, AIDS.

Observations on a Cohort of HIV-Infected Patients Undergoing Native Renal Biopsy

D. Fine, P. Scheel, G. Lucas, 2008, American Journal of Nephrology.

Chronic kidney disease incidence, and progression to end-stage renal disease, in HIV-infected individuals: a tale of two races.

Richard D Moore, B. Lau, D. Fine, 2008, The Journal of infectious diseases.

Hepatitis C viremia and the risk of chronic kidney disease in HIV-infected individuals.

Richard D Moore, D. Fine, T. Sterling, 2013, The Journal of infectious diseases.

Pharmacotherapeutic options for kidney disease in HIV positive patients

G. Lucas, M. Atta, Anam Tariq, 2020, Expert opinion on pharmacotherapy.

Renal injury and human immunodeficiency virus: what remains after 30 years?

S. de Seigneux, G. Lucas, 2019, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Association of APOL1 Genotype with Renal Histology among Black HIV-Positive Patients Undergoing Kidney Biopsy.

C. Winkler, D. Fine, K. Skorecki, 2016, Clinical journal of the American Society of Nephrology : CJASN.

HIV-associated nephropathy patients with and without apolipoprotein L1 gene variants have similar clinical and pathologic characteristics

C. Winkler, D. Fine, J. Kopp, 2012, Kidney international.

An Improvement in Virologic Response to Highly Active Antiretroviral Therapy in Clinical Practice From 1996 Through 2002

Richard D Moore, K. Gebo, G. Lucas, 2005, Journal of acquired immune deficiency syndromes.

Kidney biopsy in HIV: beyond HIV-associated nephropathy.

D. Fine, M. Perazella, G. Lucas, 2008, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Risk Factors for Vitamin D Deficiency among HIV-Infected and Uninfected Injection Drug Users

T. Brown, G. Lucas, S. Mehta, 2014, PloS one.

Illicit drug use and HIV-1 disease progression: a longitudinal study in the era of highly active antiretroviral therapy.

Richard D Moore, R. Chaisson, Michael E Griswold, 2006, American journal of epidemiology.

Burden of hepatitis C virus disease and access to hepatitis C virus services in people who inject drugs in India: a cross-sectional study.

O. Laeyendecker, T. Quinn, D. Celentano, 2015, The Lancet. Infectious diseases.

Awareness of and willingness to use pre-exposure prophylaxis (PrEP) among people who inject drugs and men who have sex with men in India: Results from a multi-city cross-sectional survey

D. Celentano, S. Solomon, S. Solomon, 2021, PloS one.

Integrated HIV testing, prevention, and treatment intervention for key populations in India: a cluster-randomised trial.

Elizabeth L. Ogburn, E. Ogburn, O. Laeyendecker, 2019, The lancet. HIV.

Psychosocial barriers to viral suppression in a community-based sample of HIV-positive men who have sex with men and people who inject drugs in India.

D. Celentano, S. Solomon, S. Shanmugam, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Epidemiology of HIV and hepatitis C infection among women who inject drugs in Northeast India: a respondent‐driven sampling study

D. Celentano, S. Solomon, G. Lucas, 2017, Addiction.

HIV, Cocaine Use, and Hepatitis C Virus: A Triad of Nontraditional Risk Factors for Subclinical Cardiovascular Disease

D. Fine, J. Stein, G. Lucas, 2016, Arteriosclerosis, thrombosis, and vascular biology.

Drug Interactions and Antiretroviral Drug Monitoring

G. Lucas, M. Estrella, M. Foy, 2014, Current HIV/AIDS Reports.

A ten-year analysis of the incidence and risk factors for acute pancreatitis requiring hospitalization in an urban HIV clinical cohort.

Richard D Moore, K. Gebo, G. Lucas, 2008, AIDS patient care and STDs.

Highly active antiretroviral therapy and the incidence of HIV-1-associated nephropathy: a 12-year cohort study

Richard D Moore, J. Eustace, G. Lucas, 2004, AIDS.

Rate of comorbidities not related to HIV infection or AIDS among HIV-infected patients, by CD4 cell count and HAART use status.

Richard D Moore, K. Gebo, G. Lucas, 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Role of geospatial mapping in the planning of HIV programs

D. Celentano, S. Solomon, G. Lucas, 2021, Medicine.

Cocaine use and hypertensive renal changes in HIV-infected individuals.

D. Fine, M. Haas, P. Scheel, 2007, Clinical journal of the American Society of Nephrology : CJASN.

Factors associated with iohexol-based glomerular filtration rate slope over 36 months in HIV-negative and HIV-positive individuals

D. Fine, G. Schwartz, J. Stein, 2016, AIDS.

Adherence, drug use, and treatment failure in a methadone-clinic-based program of directly administered antiretroviral therapy.

Richard D Moore, M. McCaul, G. Lucas, 2007, AIDS patient care and STDs.

HIV clinic‐based extended‐release naltrexone versus treatment as usual for people with HIV and opioid use disorder: a non‐blinded, randomized non‐inferiority trial

Kim A. Hoffman, D. McCarty, Elizabeth H. Payne, 2022, Addiction.

Proximal tubular dysfunction and kidney injury associated with tenofovir in HIV patients: a case series

D. Fine, G. Lucas, M. Atta, 2015, Clinical kidney journal.

Substance use is associated with condomless anal intercourse among men who have sex with men in India: a partner-level analysis

D. Celentano, S. Solomon, G. Lucas, 2022, BMC Public Health.

Invasive pneumococcal disease in a cohort of HIV-infected adults: incidence and risk factors, 1990–2003

Richard D Moore, P. Barry, K. Gebo, 2006, AIDS.

Opioid use trajectory groups and changes in a physical health biomarker among HIV-positive and uninfected patients receiving opioid agonist treatment.

A. Justice, Y. Hser, D. Fiellin, 2019, Drug and Alcohol Dependence.

The north-south divide: Substance use risk, care engagement, and viral suppression among hospitalized HIV-infected patients in 11 U.S. cities

L. Metsch, D. Feaster, L. Gooden, 2015 .

Buprenorphine treatment receipt characteristics and retention among people who inject drugs at Integrated Care Centers in India

K. Mayer, S. Solomon, G. Lucas, 2022, medRxiv.

Spatiotemporal Phylodynamics of Hepatitis C Among People Who Inject Drugs in India

T. Quinn, S. Ray, P. Duggal, 2021, Hepatology.

Deep learning and social network analysis elucidate drivers of HIV transmission in a high-incidence cohort of people who inject drugs

C. Latkin, P. Duggal, S. Solomon, 2022, Science advances.

Syringe Coverage Among People Who Inject Drugs in West Virginia, USA

S. Allen, R. White, B. Weir, 2021, AIDS and Behavior.

Hazardous alcohol use, antiretroviral therapy receipt and viral suppression in people living with HIV who inject drugs in the U.S., India, Russia and Vietnam.

C. del Rio, W. El-Sadr, F. Altice, 2020, AIDS.

Expanding Substance Use Treatment Options for HIV Prevention With Buprenorphine–Naloxone: HIV Prevention Trials Network 058

D. Metzger, Y. Ruan, Y. Shao, 2015, Journal of acquired immune deficiency syndromes.

Comparison of risk factors and outcomes in HIV immune complex kidney disease and HIV-associated nephropathy.

Richard D Moore, D. Fine, G. Lucas, 2013, Clinical journal of the American Society of Nephrology : CJASN.

Primary cutaneous Aspergillus nidulans infection associated with a Hickman catheter in a patient with neutropenia.

G. Lucas, W. Merz, P. Tucker, 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Characteristics of patients with HIV and biopsy-proven acute interstitial nephritis.

D. Fine, G. Lucas, M. Atta, 2010, Clinical journal of the American Society of Nephrology : CJASN.

End-stage renal disease among HIV-infected adults in North America.

Richard D Moore, M. Gill, R. Bosch, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Clinical practice guideline for the management of chronic kidney disease in patients infected with HIV: 2014 update by the HIV Medicine Association of the Infectious Diseases Society of America.

M. Shlipak, K. Wools-Kaloustian, P. Stock, 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Highly Active Antiretroviral Therapy in a Large Urban Clinic: Risk Factors for Virologic Failure and Adverse Drug Reactions

R. Chaisson, G. Lucas, R D Moore, 1999, Annals of Internal Medicine.

Changes in HIV care continuum indicators among community-based samples of HIV-infected people who inject drugs and men who have sex with men across 21 cities in India.

D. Celentano, S. Solomon, G. Lucas, 2022, AIDS care.

Antiretroviral nephrotoxicities.

G. Lucas, G. Deray, M. Atta, 2008, Seminars in nephrology.

Community viral load, antiretroviral therapy coverage, and HIV incidence in India: a cross-sectional, comparative study.

Oliver Laeyendecker, Shanmugam Saravanan, David D Celentano, 2016, The lancet. HIV.

Directly administered antiretroviral therapy in the treatment of HIV infection: benefit or burden?

Richard D Moore, C. Flexner, G. Lucas, 2002, AIDS patient care and STDs.

New onset kidney impairment in a large pre-exposure prophylaxis demonstration project in New South Wales, Australia.

D. Winslow, G. Lucas, 2021, AIDS.

Ascertainment and Verification of End-Stage Renal Disease and End-Stage Liver Disease in the North American AIDS Cohort Collaboration on Research and Design

Richard D Moore, S. Gange, G. Lucas, 2015, AIDS research and treatment.

Comparison of initial combination antiretroviral therapy with a single protease inhibitor, ritonavir and saquinavir, or efavirenz

R. Chaisson, G. Lucas, R. Moore, 2001, AIDS.

Antiretroviral adherence, drug resistance, viral fitness and HIV disease progression: a tangled web is woven.

G. Lucas, 2005, The Journal of antimicrobial chemotherapy.

Relationship between drug resistance and HIV-1 disease progression or death in patients undergoing resistance testing

Richard D Moore, J. Gallant, G. Lucas, 2004, AIDS.

Limited effectiveness of antiviral treatment for hepatitis C in an urban HIV clinic

Richard D Moore, M. Torbenson, G. Lucas, 2006, AIDS.

Directly administered antiretroviral therapy in methadone clinics is associated with improved HIV treatment outcomes, compared with outcomes among concurrent comparison groups.

Richard D Moore, M. McCaul, G. Lucas, 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Early immunologic and virologic responses to highly active antiretroviral therapy and subsequent disease progression among HIV-infected injection drug users

D. Vlahov, J. Astemborski, N. Galai, 2007, AIDS care.

Respondent-driven sampling for identification of HIV- and HCV-infected people who inject drugs and men who have sex with men in India: A cross-sectional, community-based analysis

T. Quinn, D. Celentano, S. Solomon, 2017, PLoS medicine.

Buprenorphine use: the international experience.

D. Vlahov, L. Amass, G. Woody, 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Rhabdomyolysis in an HIV cohort: epidemiology, causes and outcomes

Richard D Moore, D. Fine, R. Warrier, 2017, BMC Nephrology.

Diverse HCV Strains And HIV URFS Identified Amongst People Who Inject Drugs In India

M. Rodgers, S. Solomon, G. Lucas, 2020, Scientific Reports.

Renal disease in patients with HIV infection: epidemiology, pathogenesis and management.

D. Fine, M. Perazella, G. Lucas, 2008, Drugs.

Substance abuse, adherence with antiretroviral therapy, and clinical outcomes among HIV-infected individuals.

G. Lucas, 2011, Life sciences.

Opioid use disorder and HIV

G. Lucas, 2021 .

Detrimental Effects of Continued Illicit Drug Use on the Treatment of HIV‐1 Infection

Richard D Moore, R. Chaisson, L. Cheever, 2001, Journal of acquired immune deficiency syndromes.

Drug use stigma, antiretroviral therapy use, and HIV viral suppression in a community-based sample of people with HIV who inject drugs

D. Celentano, Eshan U. Patel, S. Solomon, 2022, AIDS.

Adherence to HIV treatment among IDUs and the role of opioid substitution treatment (OST).

M. Carrieri, B. Spire, G. Lucas, 2007, The International journal on drug policy.

HIV Viremia and T-Cell Activation Differentially Affect the Performance of Glomerular Filtration Rate Equations Based on Creatinine and Cystatin C

B. Lau, D. Fine, G. Schwartz, 2013, PloS one.

Care Facilitation Advances Movement Along the Hepatitis C Care Continuum for Persons With Human Immunodeficiency Virus, Hepatitis C, and Substance Use: A Randomized Clinical Trial (CTN-0064)

C. del Rio, L. Metsch, D. Feaster, 2021, Open forum infectious diseases.

Nonstructured Treatment Interruptions Among Injection Drug Users in Baltimore, MD

D. Celentano, N. Galai, G. Lucas, 2009, Journal of acquired immune deficiency syndromes.

HIV care continuum among men who have sex with men and persons who inject drugs in India: barriers to successful engagement.

N. Dhingra, D. Celentano, S. Solomon, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Optimizing treatment outcomes in HIV-infected patients with substance abuse issues.

D. Celentano, G. Lucas, 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Patient-centered care for people living with multimorbidity.

C. Boyd, G. Lucas, 2014, Current opinion in HIV and AIDS.

Risk of End‐Stage Renal Disease in HIV‐Positive Potential Live Kidney Donors

L. Kucirka, S. Boswell, M. Gill, 2017, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Detrimental effects of continued illicit drug use on the treatment of HIV-1 infection.

Richard D Moore, R. Chaisson, L. Cheever, 2001 .

Contributions of traditional and HIV-related risk factors on non-AIDS-defining cancer, myocardial infarction, and end-stage liver and renal diseases in adults with HIV in the USA and Canada: a collaboration of cohort studies.

Richard D Moore, K. Anastos, S. Gange, 2019, The lancet. HIV.

Motivations for opioid and stimulant use among drug using black sexual minority men: A life course perspective.

G. Lucas, O. Heidari, Derek T. Dangerfield II, 2020, Drug and alcohol dependence.

Survival during renal replacement therapy among African Americans infected with HIV type 1 in urban Baltimore, Maryland.

Richard D Moore, D. Fine, G. Lucas, 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

HIV-associated nephropathy: epidemiology, pathogenesis, diagnosis and management

D. Fine, G. Lucas, M. Atta, 2008, Expert review of anti-infective therapy.

The Clinical Characteristics and Pathological Patterns of Postinfectious Glomerulonephritis in HIV-Infected Patients

D. Fine, G. Lucas, M. Atta, 2014, PloS one.

Barriers and Facilitators to PrEP Use Among People Who Inject Drugs in Rural Appalachia: A Qualitative Study

K. Smith, S. Allen, R. White, 2019, AIDS and Behavior.

Overlap between harm reduction and HIV service utilisation among PWID in India: Implications for HIV combination prevention.

D. Cummings, D. Celentano, S. Solomon, 2018, The International journal on drug policy.

Effect of Patient Navigation With or Without Financial Incentives on Viral Suppression Among Hospitalized Patients With HIV Infection and Substance Use: A Randomized Clinical Trial.

C. del Rio, M. Mugavero, L. Metsch, 2016, JAMA.

Nursing and Health Care Preferences Among Opioid and Stimulant Using Black Sexual Minority Men: An Exploratory Study

G. Lucas, O. Heidari, D. Dangerfield, 2020, The Journal of the Association of Nurses in AIDS Care : JANAC.

Mobile low-threshold buprenorphine integrated with infectious disease services.

B. Weir, S. Sherman, G. Lucas, 2021, Journal of substance abuse treatment.

Getting to 90: linkage to HIV care among men who have sex with men and people who inject drugs in India

D. Celentano, S. Solomon, S. Solomon, 2016, AIDS care.

Awareness, perception and utilization of a mobile health clinic by people who use drugs

S. Sherman, G. Lucas, K. Page, 2022, Annals of medicine.

Role of HIV-1 DNA levels as clinical marker of HIV-1-associated nephropathies.

P. Cluzel, D. Sène, G. Lucas, 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

High HIV prevalence and incidence among MSM across 12 cities in India

Elizabeth L. Ogburn, Oliver Laeyendecker, Gregory M. Lucas, 2015, AIDS.

Directly Administered Antiretroviral Therapy for HIV-Infected Individuals in Opioid Treatment Programs: Results from a Randomized Clinical Trial

Richard D Moore, C. Rand, N. Galai, 2013, PloS one.

Gender Differences in Factors Related to HIV Risk Behaviors among People Who Inject Drugs in North-East India

D. Celentano, S. Solomon, G. Lucas, 2017, PloS one.

Mortality among injection drug users in Chennai, India (2005–2008)

D. Celentano, S. Solomon, S. Solomon, 2009, AIDS.

Survival in an Urban HIV‐1 Clinic in the Era of Highly Active Antiretroviral Therapy: A 5‐Year Cohort Study

Richard D Moore, R. Chaisson, G. Lucas, 2003, Journal of acquired immune deficiency syndromes.

Participant Characteristics and HIV Risk Behaviors Among Individuals Entering Integrated Buprenorphine/Naloxone and HIV Care

T. Flanigan, J. Mitty, D. Fiellin, 2011, Journal of acquired immune deficiency syndromes.

Voucher incentives improve linkage to and retention in care among HIV-infected drug users in Chennai, India.

S. Solomon, S. Solomon, G. Lucas, 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Clinic-Based Treatment of Opioid-Dependent HIV-Infected Patients Versus Referral to an Opioid Treatment Program

Richard D Moore, B. Lau, D. Fiellin, 2010, Annals of Internal Medicine.

End-stage renal disease and chronic kidney disease in a cohort of African-American HIV-infected and at-risk HIV-seronegative participants followed between 1988 and 2004

Richard D Moore, D. Vlahov, N. Galai, 2007, AIDS.

Young and invisible: a qualitative study of service engagement by people who inject drugs in India

K. Mayer, S. Solomon, G. Lucas, 2021, BMJ Open.

Drug use stigma and its association with active hepatitis C virus infection and injection drug use behaviors among community-based people who inject drugs in India.

O. Laeyendecker, T. Quinn, D. Celentano, 2021, The International journal on drug policy.

Young and invisible: an explanatory model for service engagement by people who inject drugs in India

K. Mayer, S. Solomon, G. Lucas, 2021, medRxiv.

Young people who inject drugs in India have high HIV incidence and behavioural risk: a cross‐sectional study

S. Solomon, G. Lucas, S. Harris, 2019, Journal of the International AIDS Society.

O34 LIMITED ACCESS TO HCV TESTING AND TREATMENT AMONG INJECTION DRUG USERS ACROSS INDIA

O. Laeyendecker, T. Quinn, S. Solomon, 2014 .

Associations between fentanyl use and initiation, persistence, and retention on medications for opioid use disorder among people living with uncontrolled HIV disease.

P. Korthuis, L. Fanucchi, G. Lucas, 2021, Drug and alcohol dependence.

Role of direct and indirect social and spatial ties in the diffusion of HIV and HCV among people who inject drugs: a cross-sectional community-based network analysis in New Delhi, India

Elizabeth L. Ogburn, C. Latkin, P. Duggal, 2021, eLife.

Correlates and Longitudinal Renal and Cardiovascular Implications of FGF23 Levels in HIV-Positive Individuals

D. Fine, J. Stein, G. Lucas, 2016, PloS one.

Psychosocial Factors Associated with Problem Drinking Among Substance Users with Poorly Controlled HIV Infection

Ahnalee M. Brincks, C. del Rio, L. Metsch, 2018, Alcohol and alcoholism.

Impact of early versus deferred antiretroviral therapy on estimated glomerular filtration rate in HIV-positive individuals in the START trial.

A. Mocroft, H. Furrer, A. Clarke, 2017, International journal of antimicrobial agents.

Vitamin D deficiency and persistent proteinuria among HIV-infected and uninfected injection drug users

D. Fine, T. Brown, G. Lucas, 2012, AIDS.

Incidence of, Risk Factors for, Clinical Presentation, and 1-Year Outcomes of Infective Endocarditis in an Urban HIV Cohort

Richard D Moore, L. Wilson, K. Gebo, 2006, Journal of acquired immune deficiency syndromes.

Initiation of Antiretroviral Therapy in the Hospital Is Associated With Linkage to Human Immunodeficiency Virus (HIV) Care for Persons Living With HIV and Substance Use Disorder

L. Metsch, L. Gooden, Yue Pan, 2021 .

Initiation of Antiretroviral Therapy in the Hospital is Associated with Linkage to HIV Care for Persons Living with HIV and Substance Use.

C. del Rio, L. Metsch, D. Feaster, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Impact of the COVID‐19 pandemic on HIV prevention and care services among key populations across 15 cities in India: a longitudinal assessment of clinic‐based data

D. Celentano, S. Solomon, G. Lucas, 2022, Journal of the International AIDS Society.

Poor validity of urine dipstick as a screening tool for proteinuria in HIV-positive patients.

D. Fine, M. Siedner, M. Perazella, 2008, Journal of acquired immune deficiency syndromes.

Short-term safety of buprenorphine/naloxone in HIV-seronegative opioid-dependent Chinese and Thai drug injectors enrolled in HIV Prevention Trials Network 058.

D. Metzger, Y. Shao, D. Celentano, 2012, The International journal on drug policy.

Study design and participant characteristics of a randomized controlled trial of directly administered antiretroviral therapy in opioid treatment programs

Richard D Moore, C. Rand, N. Galai, 2011, BMC infectious diseases.

Longitudinal Assessment of Proximal Tubular Dysfunction in HIV Seropositive and Seronegative Persons: Correlates and Implications

D. Fine, G. Schwartz, G. Lucas, 2017, Journal of acquired immune deficiency syndromes.

Predictors of complication after percutaneous ultrasound-guided kidney biopsy in HIV-infected individuals: possible role of hepatitis C and HIV co-infection.

D. Fine, G. Lucas, M. Atta, 2009, Clinical journal of the American Society of Nephrology : CJASN.

Impact of generic antiretroviral therapy (ART) and free ART programs on time to initiation of ART at a tertiary HIV care center in Chennai, India

S. Solomon, S. Solomon, G. Lucas, 2013, AIDS care.

Directly administered antiretroviral therapy in an urban methadone maintenance clinic: a nonrandomized comparative study.

Richard D Moore, G. Lucas, P. Weidle, 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Outcomes of Renal Transplantation in HIV-1 Associated Nephropathy

D. Fine, G. Lucas, M. Atta, 2015, PloS one.

The North-South Divide: Substance Use Risk, Care Engagement, and Viral Suppression Among Hospitalized Human Immunodeficiency Virus–Infected Patients in 11 US Cities

C. del Rio, L. Metsch, D. Feaster, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Adherence to antiretroviral therapy: An update of current concepts

A. Wu, L. Cheever, G. Lucas, 2004, Current HIV/AIDS reports.

Hepatotoxicity in a 52-week randomized trial of short-term versus long-term treatment with buprenorphine/naloxone in HIV-negative injection opioid users in China and Thailand.

D. Metzger, Y. Ruan, Y. Shao, 2014, Drug and alcohol dependence.

Clinic-based Treatment for Opioid-dependent HIV-infected Patients versus Referral to an Opioid Treatment Program : A Randomized Controlled Trial

Woodson, Richard D Moore, B. Lau, 2010 .

Association of HIV Suppression With Kidney Disease Progression Among HIV-Positive African Americans With Biopsy-Proven Classic FSGS

D. Fine, G. Lucas, M. Atta, 2018, Journal of acquired immune deficiency syndromes.

Highly active antiretroviral therapy and the incidence of HIV-1-associated nephropathy: a 12-year cohort study

Richard D Moore, J. Eustace, G. Lucas, 2004 .

Cross-sectional and longitudinal performance of creatinine- and cystatin C-based estimating equations relative to exogenously measured glomerular filtration rate in HIV-positive and HIV-negative persons.

G. Schwartz, G. Lucas, M. Atta, 2020, Journal of acquired immune deficiency syndromes.

Renal injury and human immunodeficiency virus: what remains after 30 years?

G. Lucas, S. Seigneux, 2020 .

Exploring multilevel determinants of co-occurring violence, HIV, mental health and substance use problems

S. Solomon, G. Lucas, Bushra Sabri, 2021, Journal of ethnic & cultural diversity in social work.

Survival during renal replacement therapy among African Americans infected with HIV type 1 in urban Baltimore, Maryland.

D. Fine, G. Lucas, S. Mehta, 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

End-stage renal disease among HIV-infected adults in North America.

Sally S Bebawy, K. Anastos, S. Gange, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Kidney function and the risk of cardiovascular events in HIV-1-infected patients

D. Fine, G. Nadkarni, G. Lucas, 2010, AIDS.

Participant Characteristics and HIV Risk Behaviors Among Individuals Entering Integrated Buprenorphine/Naloxone and HIV Care

T. Flanigan, J. Mitty, D. Fiellin, 2011, Journal of acquired immune deficiency syndromes.

Temporal change in population-level prevalence of detectable HIV viraemia and its association with HIV incidence in key populations in India: a serial cross-sectional study.

O. Laeyendecker, D. Celentano, Eshan U. Patel, 2021, The lancet. HIV.

Respondent-driven sampling is more efficient than facility-based strategies at identifying undiagnosed people who inject drugs living with HIV in India.

B. Lau, C. Latkin, S. Solomon, 2023, Drug and alcohol dependence.

Community viral load, antiretroviral therapy coverage, and HIV incidence in India: a cross-sectional, comparative study.

O. Laeyendecker, D. Celentano, S. Solomon, 2016, The lancet. HIV.